<DOC>
	<DOCNO>NCT01378858</DOCNO>
	<brief_summary>This randomized trial evaluate whether varenicline directly observe therapy provide methadone clinic efficacious self-administered varenicline promote smoke cessation enhance adherence .</brief_summary>
	<brief_title>Varenicline Smoking Cessation Treatment Methadone Maintenance Patients</brief_title>
	<detailed_description>There mark prevalence tobacco use tobacco-related disease among methadone maintenance patient . Varenicline 's demonstrated efficacy may generalizable methadone maintain smoker poor adherence , highly prevalent among drug user . Adherence smoke cessation medication strongly associate cessation , one factor show increase cessation among methadone maintain smoker , strategy promote smoke cessation medication adherence evaluate methadone patient . Based Information , Motivation , Behavior model , investigator plan directly observe therapy ( DOT ) -based intervention target behavioral skill necessary optimal adherence . Because methadone clinic-based DOT intervention show improve medication adherence clinical outcome HIV TB , investigator plan determine randomized trial whether DOT varenicline provide methadone clinic efficacious self-administered varenicline promote smoke cessation enhance adherence . The investigator also evaluate moderate effect drug alcohol use psychiatric symptom DOT effect . The investigator hypothesize subject mDOT arm great 7 day point prevalence abstinence 12 week , reduction cigarettes/day , time first daily cigarette , â‰¥ 24 hour quit attempt , 7 day point prevalence abstinence 24 week compare subject receive self administer varenicline . The investigator also hypothesize adherence mDOT arm high TAU arm . Lastly investigator hypothesize ongoing illicit drug use psychiatric symptom moderate effect mDOT adherence .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Age 18 year old English speaking Smoked least 100 cigarettes/lifetime Smoke 5 cigarette per day Interested quit smoking ( preparation contemplation stage change ) Enrolled Einstein/Montefiore methadone program 12 week Receiving methadone clinic three , four , five six time per week No 2 methadone clinic miss prior 14 day Agree use contraception duration trial ( among woman reproductive potential ) Willing participate study component Able provide inform consent Serious unstable HIV/AIDS , liver , cardiovascular , pulmonary disease Psychiatric instability Women pregnant , breastfeeding , contemplate pregnancy Creatinine clearance &lt; 30 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Smoking</keyword>
	<keyword>Substance-Related Disorders</keyword>
	<keyword>medication adherence</keyword>
	<keyword>Methadone</keyword>
</DOC>